{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:30:56Z","timestamp":1792765856830,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11328-0","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T21:34:39Z","timestamp":1754688879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of multidrug resistant gram-negative bacteria and associated factors among gram-negative blood culture isolates at Tikur Anbessa Specialized Hospital: a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Eskedar Ferdu","family":"Azerefegne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel Tenaw","family":"Tasamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilahun Bizuayehu","family":"Demass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel Girma","family":"Tessema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wondwossen Amogne","family":"Degu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"issue":"12","key":"11328_CR1","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.1099\/ijsem.0.001485","volume":"66","author":"M Adeolu","year":"2016","unstructured":"Adeolu M, Alnajar S, Naushad S, Gupta RS. Genome-based phylogeny and taxonomy of the \u2018enterobacteriales\u2019: proposal for enterobacterales ord. Nov. Divided into the families enterobacteriaceae, Erwiniaceae fam. Nov., pectobacteriaceae fam. Nov., Yersiniaceae fam. Nov., hafniaceae fam. Nov., Morganellaceae fam. Nov., and Budviciaceae fam. Nov. Int J Syst Evol Microbiol. 2016;66(12):5575\u201399.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"5","key":"11328_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ijantimicag.2012.01.018","volume":"39","author":"MK O\u2019Shea","year":"2012","unstructured":"O\u2019Shea MK. Acinetobacter in modern warfare. Int J Antimicrob Agents. 2012;39(5):363\u201375.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"11328_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","volume":"37","author":"Z Pang","year":"2019","unstructured":"Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019;37(1):177\u201392.","journal-title":"Biotechnol Adv"},{"issue":"3","key":"11328_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"11328_CR5","unstructured":"2019. Antibiotic resistance threats in the United States, Atlanta G. 2019 Nov. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/82532"},{"issue":"3","key":"11328_CR6","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1016\/S2666-5247(22)00329-9","volume":"4","author":"J Reyes","year":"2023","unstructured":"Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, et al. Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. Lancet Microbe. 2023;4(3):e159\u201370.","journal-title":"Lancet Microbe"},{"key":"11328_CR7","unstructured":"WHO, Prioritization of Pathogens to guide discovery, Research and Development of New Antibiotics for\u00a0Drug-Resistant Bacterial Infections, Including Tuberculosis. 2017."},{"key":"11328_CR8","unstructured":"WHO Antibiotics Portal. Cited 2024 Apr 25. Available from: https:\/\/aware.essentialmeds.org\/groups"},{"issue":"10325","key":"11328_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355.","journal-title":"Lancet"},{"issue":"1","key":"11328_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13756-020-00750-5","volume":"9","author":"O Ayobami","year":"2020","unstructured":"Ayobami O, Willrich N, Suwono B, Eckmanns T, Markwart R. The epidemiology of carbapenem-non-susceptible Acinetobacter species in europe: analysis of EARS-Net data from 2013 to 2017. Antimicrob Resist Infect Control. 2020;9(1):89.","journal-title":"Antimicrob Resist Infect Control"},{"key":"11328_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8853053","volume":"2020","author":"B Alemnew","year":"2020","unstructured":"Alemnew B, Biazin H, Demis A, Abate Reta M. Bacterial profile among patients with suspected bloodstream infections in ethiopia: A systematic review and Meta-Analysis. Int J Microbiol. 2020;2020:1\u201312.","journal-title":"Int J Microbiol"},{"issue":"1","key":"11328_CR12","doi-asserted-by":"publisher","first-page":"15882","DOI":"10.1038\/s41598-021-95314-x","volume":"11","author":"M Birru","year":"2021","unstructured":"Birru M, Woldemariam M, Manilal A, Aklilu A, Tsalla T, Mitiku A, et al. Bacterial profile, antimicrobial susceptibility patterns, and associated factors among bloodstream infection suspected patients attending Arba minch general hospital, Ethiopia. Sci Rep. 2021;11(1):15882.","journal-title":"Sci Rep"},{"issue":"12","key":"11328_CR13","doi-asserted-by":"publisher","first-page":"e0144944","DOI":"10.1371\/journal.pone.0144944","volume":"10","author":"T Seboxa","year":"2015","unstructured":"Seboxa T, Amogne W, Abebe W, Tsegaye T, Azazh A, Hailu W, et al. High mortality from blood stream infection in addis ababa, ethiopia, is due to antimicrobial resistance. PLoS ONE. 2015;10(12):e0144944.","journal-title":"PLoS ONE"},{"issue":"3","key":"11328_CR14","doi-asserted-by":"publisher","first-page":"dlaa039","DOI":"10.1093\/jacamr\/dlaa039","volume":"2","author":"M Semret","year":"2020","unstructured":"Semret M, Abebe W, Kong LY, Alemayehu T, Beyene T, Libman MD, et al. Prolonged empirical antibiotic therapy is correlated with bloodstream infections and increased mortality in a tertiary care hospital in ethiopia: bacteriology testing matters. JAC Antimicrob Resist. 2020;2(3):dlaa039.","journal-title":"JAC Antimicrob Resist"},{"issue":"1","key":"11328_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13756-022-01122-x","volume":"11","author":"MH Legese","year":"2022","unstructured":"Legese MH, Asrat D, Swedberg G, Hasan B, Mekasha A, Getahun T, et al. Sepsis: emerging pathogens and antimicrobial resistance in Ethiopian referral hospitals. Antimicrob Resist Infect Control. 2022;11(1):83.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"11328_CR16","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1038\/s41598-023-29337-x","volume":"13","author":"A Bitew","year":"2023","unstructured":"Bitew A, Adane A, Abdeta A. Bacteriological spectrum, extended-spectrum \u03b2-lactamase production and antimicrobial resistance pattern among patients with bloodstream infection in addis Ababa. Sci Rep. 2023;13(1):2071.","journal-title":"Sci Rep"},{"key":"11328_CR17","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.2147\/IDR.S371654","volume":"15","author":"D Beshah","year":"2022","unstructured":"Beshah D, Desta A, Belay G, Abebe T, Gebreselasie S, Sisay Tessema T. Antimicrobial resistance and associated risk factors of Gram-Negative bacterial bloodstream infections in Tikur Anbessa specialized hospital, addis Ababa. Infect Drug Resist. 2022;15:5043\u201359.","journal-title":"Infect Drug Resist"},{"key":"11328_CR18","unstructured":"M100 Performance Standards for Antimicrobial Susceptibility Testing. 33rd Edition, M100ED33. CLSI; 2023. https:\/\/iacld.com\/UpFiles\/Documents\/672a1c7c-d4ad-404e-b10e-97c19e21cdce.pdf."},{"issue":"6","key":"11328_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676\u201382.","journal-title":"Am J Epidemiol"},{"issue":"Supplement","key":"11328_CR20","doi-asserted-by":"publisher","first-page":"S513","DOI":"10.1097\/01.CCM.0000143119.41916.5D","volume":"32","author":"JC Marshall","year":"2004","unstructured":"Marshall JC, Maier RV, Jimenez M, Dellinger EP. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004;32(Supplement):S513\u201326.","journal-title":"Crit Care Med"},{"issue":"11","key":"11328_CR21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247.","journal-title":"Intensive Care Med"},{"key":"11328_CR22","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.2147\/IDR.S370326","volume":"15","author":"N Shi","year":"2022","unstructured":"Shi N, Kang J, Wang S, Song Y, Yin D, Li X, et al. Bacteriological profile and antimicrobial susceptibility patterns of Gram-Negative bloodstream infection and risk factors associated with mortality and drug resistance: A retrospective study from shanxi, China. Infect Drug Resist. 2022;15:3561\u201378.","journal-title":"Infect Drug Resist"},{"key":"11328_CR23","doi-asserted-by":"publisher","unstructured":"Kalayci Cekin Z. Bloodstream infections caused by multidrug resistant bacteria: clinical and Microbiological features and mortality. SiSli Etfal hastanesi tip Bulteni \/. Med Bull Sisli Hosp. 2023;416\u201325. https:\/\/doi.org\/10.14744\/semb.2023.31697.","DOI":"10.14744\/semb.2023.31697"},{"issue":"1","key":"11328_CR24","doi-asserted-by":"publisher","first-page":"e0001414","DOI":"10.1371\/journal.pgph.0001414","volume":"3","author":"K Yamba","year":"2023","unstructured":"Yamba K, Lukwesa-Musyani C, Samutela MT, Kapesa C, Hang\u2019ombe MB, Mpabalwani E, et al. Phenotypic and genotypic antibiotic susceptibility profiles of Gram-negative bacteria isolated from bloodstream infections at a referral hospital, lusaka, Zambia. PLOS Global Public Health. 2023;3(1):e0001414.","journal-title":"PLOS Global Public Health"},{"issue":"2","key":"11328_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/antibiotics12020255","volume":"12","author":"ES Donkor","year":"2023","unstructured":"Donkor ES, Muhsen K, Johnson SAM, Kotey FCN, Dayie NTKD, Tetteh-Quarcoo PB, et al. Multicenter surveillance of antimicrobial resistance among Gram-Negative Bacteria isolated from bloodstream infections in Ghana. Antibiotics. 2023;12(2):255.","journal-title":"Antibiotics"},{"key":"11328_CR26","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.2147\/IDR.S403360","volume":"16","author":"A Abdeta","year":"2023","unstructured":"Abdeta A, Negeri AA, Beyene D, Adamu E, Fekede E, Fentaw S, et al. Prevalence and trends of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter species isolated from clinical specimens at the Ethiopian public health institute, addis ababa, ethiopia: A retrospective analysis. Infect Drug Resist. 2023;16:1381\u201390.","journal-title":"Infect Drug Resist"},{"key":"11328_CR27","doi-asserted-by":"publisher","unstructured":"Palacios-Baena ZR, Giannella M, Manissero D, Rodr\u00edguez-Ba\u00f1o J, Viale P, Lopes S, et al. Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review. Clinical Microbiology and Infection. Volume 27. Elsevier B.V.; 2021. pp. 228\u201335. https:\/\/doi.org\/10.1016\/j.cmi.2020.10.016.","DOI":"10.1016\/j.cmi.2020.10.016"},{"issue":"5","key":"11328_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jmii.2011.12.009","volume":"45","author":"ST Huang","year":"2012","unstructured":"Huang ST, Chiang MC, Kuo SC, Lee YT, Chiang TH, Yang SP, et al. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect. 2012;45(5):356\u201362.","journal-title":"J Microbiol Immunol Infect"},{"key":"11328_CR29","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-Galera S, Bravo-Ferrer JM, Paniagua M, Kostyanev T, de Kraker MEA, Feifel J et al. Risk factors for infections caused by carbapenem-resistant enterobacterales: an international matched case-control-control study (EURECA). EClinicalMedicine. 2023;57. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101871.","DOI":"10.1016\/j.eclinm.2023.101871"},{"key":"11328_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jgar.2022.04.005","volume":"30","author":"Y Gao","year":"2022","unstructured":"Gao Y, Chen M, Cai M, Liu K, Wang Y, Zhou C, et al. An analysis of risk factors for carbapenem-resistant Enterobacteriaceae infection. J Glob Antimicrob Resist. 2022;30:191\u20138.","journal-title":"J Glob Antimicrob Resist"},{"key":"11328_CR31","doi-asserted-by":"publisher","unstructured":"Cogliati Dezza F, Covino S, Petrucci F, Sacco F, Viscido A, Gavaruzzi F et al. Risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infections and related mortality in critically ill patients with CRAB colonization. JAC Antimicrob Resist. 2023;5(4). https:\/\/doi.org\/10.1093\/jacamr\/dlad096.","DOI":"10.1093\/jacamr\/dlad096"},{"issue":"7","key":"11328_CR32","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1099\/jmm.0.001222","volume":"69","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wang Q, Zhao C, Chen H, Li H, Wang H, et al. Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in Acinetobacter baumannii complex bacteraemia: experience from the Chinese antimicrobial resistance surveillance of nosocomial infections (CARES) network. J Med Microbiol. 2020;69(7):949\u201359.","journal-title":"J Med Microbiol"},{"key":"11328_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2147\/IDR.S396428","volume":"16","author":"X Wei","year":"2023","unstructured":"Wei X, Li L, Li M, Liang H, He Y, Li S. Risk factors and outcomes of patients with Carbapenem-Resistant Pseudomonas aeruginosa bloodstream infection. Infect Drug Resist. 2023;16:337\u201346.","journal-title":"Infect Drug Resist"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11328-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11328-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11328-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T19:30:14Z","timestamp":1757359814000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11328-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11328"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11328-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki (2013) and was approved by the Institutional Review Board (IRB) of the Department of Internal Medicine, College of Health Sciences, Addis Ababa University. Informed consent to take part in the study was not obtained from patients since the study is retrospective and only used secondary data in accordance with the institutional review boards data protection policy. Waiver for informed consent was given by IRB of Department of Internal Medicine, College of Health Sciences, Addis Ababa University. The IRB protocol number is 101\/2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1006"}}